Boston Scientific
493 hedge funds and large institutions have $23.9B invested in Boston Scientific in 2016 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 178 increasing their positions, 189 reducing their positions, and 51 closing their positions.
73% more call options, than puts
Call options by funds: $39.9M | Put options by funds: $23.1M
23% more funds holding in top 10
Funds holding in top 10: 13 → 16 (+3)
1.11% more ownership
Funds ownership: 92.7% → 93.81% (+1.1%)
4% more capital invested
Capital invested by funds: $23B → $23.9B (+$894M)
6% less repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 189
8% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 51
2% less funds holding
Funds holding: 502 → 493 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$295M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$224M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$179M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$152M |
| 5 |
FAM
Fred Alger Management
New York
|
+$64.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$142M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$96.9M |
| 3 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
-$72.1M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$64.5M |
| 5 |
Renaissance Technologies
New York
|
-$50.1M |
BSX Hedge Fund Activity: Q1 2016 in Review
493 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2016, worth a combined $23.9B — up 3.9% from $23B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of BSX and 47 opened new positions — a net loss of 4 holders — while 189 trimmed existing stakes and 178 added.
The largest buyer was Fidelity Investments, adding an estimated $295M. The largest seller was JP Morgan Chase, cutting an estimated $142M.
- 493 institutional investors held Boston Scientific (BSX) as of Q1 2016, down from 502 in Q4 2015.
- Funds reported $23.9B of Boston Scientific stock for Q1 2016, up 3.9% quarter-over-quarter.
- 47 funds opened new Boston Scientific positions in Q1 2016 and 51 closed out, a net change of -4 holders.
- The largest Boston Scientific buyer in Q1 2016 was Fidelity Investments, an estimated $295M added.
- The largest Boston Scientific seller in Q1 2016 was JP Morgan Chase, an estimated $142M sold.
Based on aggregated 13F filings for Q1 2016.